Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Autofluorescence endoscopy improves Barrett's diagnosis

The latest Endoscopy shows that autofluorescence endoscopy vs standard 4-quadrant biopsy improves diagnostic yield for neoplasia in Barrett's esophagus.

News image

fiogf49gjkf04

The reference surveillance method in patients with Barrett's esophagus is careful endoscopic observation, with targeted as well as random 4-quadrant biopsies.

Autofluorescence endoscopy may make it easier to locate neoplasia.

Dr Borovicka and colleagues from Switzerland elucidated the diagnostic accuracy of surveillance with Autofluorescence endoscopy-guided plus 4-quadrant biopsies vs the conventional approach.

The research team enrolled a total of 187 of 200 consecutive Barrett's esophagus patients.

Of these patients, 73% were male with a mean age 67 years, who underwent endoscopy for Barrett's esophagus in 4 study centers.

In phase 1, patients were randomly assigned to either-targeted biopsy followed by 4-quadrant biopsies or conventional endoscopic surveillance with 4-quadrant biopsies.

The team excluded patients with early cancer or high-grade dysplasia, who underwent endoscopic or surgical treatment.

Autofluorescence endoscopy yielded high-grade dysplasia rates of 12%
Endoscopy

Patients who declined to participate in phase 2 of the study were also excluded.

The research team reported that 130 patients remained.

These patients were examined again with the alternative method after a mean of 10 weeks, using the same methods described.

The team's main study parameter was the detection of early cancer, adenocarcinoma or high-grade dysplasia.

The secondary aim in the second phase was the additional value of the Autofluorescence endoscopy-guided approach after conventional surveillance.

The researchers derived test accuracy measures from the first study phase.

The research team found that the Autofluorescence endoscopy yielded adenocarcinoma/high-grade dysplasia at rates of 12%.

The team noted that conventional approaches yielded adenocarcinoma/high-grade dysplasia rates of 5% on a per-patient basis.

With Autofluorescence endoscopy, previously unrecognized adenocarcinoma or high-grade dysplasia lesions were identified in 4% of the patients.

The researchers observed new lesions in 1% with the conventional approach.

Of the 19 adenocarcinoma/high-grade dysplasia lesions detected during Autofluorescence endoscopy in the first study phase, 8 were visualized.

A further 11 were only detected using untargeted 4-quadrant biopsies, giving a sensitivity of 42%.

Of the 766 biopsies classified at histology as being nonneoplastic, 58 appeared suspicious.

The specificity was 92%, with a positive predictive value of 12%, and a negative predictive value 99%.

In the second phase using Autofluorescence endoscopy, the team detected 2 further lesions in addition to the initial alternative approach in 3% of cases.

Conventional endoscopy identified only 2% of lesions.

Dr Borovicka's team concluded, “In this referral Barrett's esophagus population with a higher prevalence of neoplastic lesions, the Autofluorescence endoscopy -guided approach improved the diagnostic yield for neoplasia.”

“In comparison with the conventional approach using 4-quadrant biopsies.”

“However, Autofluorescence endoscopy alone was not suitable for replacing the standard 4-quadrant biopsy protocol.”

Endoscopy 2006: 38(9): 867-72
26 September 2006

Go to top of page Email this page Email this page to a colleague

 20 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 20 April 2018 
Obesity and physical activity in diverticulosis
 20 April 2018 
Worldwide H.pylori prevalence
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Physician perception of IBD trial results
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 06 April 2018 
Microbiome in athletes vs sedentary subjects
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 05 April 2018 
Scoring system identifies cancer risk in Barrett's
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
PPI and risk of stroke
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 22 March 2018 
Mechanisms of action in patients with IBS
 21 March 2018 
Panel markers for early detection of colon cancer

 21 March 2018 
Blood test differentiates celiac disease
 21 March 2018 
Patient characteristics and colonoscopy preparation

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us